The nation of Zimbabwe has rejected a significant American health deal valued at $367m (£272m) over five years over the United States' request for sensitive biological samples.
This move was revealed after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government representative later clarified that the US was requesting biological samples for research and commercial purposes but was not willing to share the benefits from future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued dialogue to secure a agreement suitable to all parties so the country's critical HIV programme can continue.
Wider Implications
This rejection comes after a similar case in neighbouring Kenya, where a high court blocked a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
As per statements, 16 African countries have to date agreed to these new agreements, constituting more than $18.3bn in new funding.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no equivalent promise of access to any medical innovations – such as new medicines or tests – that could result from that provided information," Mangwana explained.
"Effectively, our country would supply the raw materials for medical research with no assurance that the end products would be accessible to our population if a future pandemic arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the global health body and its push of bilateral deals were undermining systems already set up through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to manage potential global health emergencies.
"This framework is intended to ensure that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how subsequent co-operation could be designed in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but suggested that negotiations need to persist considering a large portion of the nation's Aids initiatives were funded by foreign aid.
"If specific concerns exist, such as those relating to information security or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," the group added.
The situation emphasises the continuing tensions between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.